share_log

可靠股份(301009):成人失禁用品持续增长 国内外ODM 业务共同发展

Reliable shares (301009): Adult incontinence products continue to grow, domestic and foreign ODM business develops together

天風證券 ·  May 5, 2022 14:02  · Researches

Reliable Co., Ltd. released its performance report for the first quarter of 2021 and 2022 on April 23.

The company achieved revenue of 1,186 billion yuan in 2021, a year-on-year decrease of 27.44%. Among them, 21Q1/Q2/Q3/Q4 revenue was 333 million/298 million/236 million/320 million yuan, respectively, a year-on-year change of +6.06%/-38.72%/-45.54%/-20.44%. 2022Q1 achieved revenue of 322 million dollars, a year-on-year decrease of 3.34%.

By product, in 2021, the company's baby care/adult incontinence products/pet hygiene products/masks and other products achieved revenue of 612 million/464 million/88 million/023 million yuan, a year-on-year change of -34.8%/+8.1%/+13.9%/-88.1%, accounting for 51.6%/39.1%/7.4%/1.9% of revenue, respectively.

In terms of sales model, the company's own brand sales revenue in 2021 was 391 million yuan, a year-on-year decrease of 12.05%, excluding the impact of epidemic prevention materials revenue, an increase of 6.15%; ODM business sales revenue was 778 million, a year-on-year decrease of 33.81%, excluding the impact of revenue from epidemic prevention materials, a year-on-year decrease of 28.01%.

By region, the company's revenue in domestic/overseas regions was 604 million/582 million yuan respectively, a year-on-year decrease of 27.13%/27.77%.

Gross profit margin: The company's gross profit margin in 2021 was 18.64%, down 9.19pcts year on year; Q1 gross profit margin in 2022 was 12.07%, down 13.30pcts year on year.

Expense side: In 2021, the company's sales/management/R&D/financial expense ratio was 7.64%/3.13%/4.15%/-0.53%, respectively, with a year-on-year change of 3.64pcts/1.61pcts/0.55pcts/-1.90pcts.

The sales/management/R&D/financial expense ratios of 2022Q1 were 6.90%/2.04%/3.53%/-1.64%, respectively, with a year-on-year change of 1.35 pcts/0.38 pcts/0.32 pcts/-1.47 pcts.

Net profit: In 2021, net profit was 40 million yuan, a year-on-year decrease of 81.43%, and a year-on-year net profit margin of 3.35%, a year-on-year decrease of 9.74pcts. The net profit for 2022Q1 was 0.02 billion yuan, a year-on-year decrease of 95.14%, and a year-on-year net interest rate of 0.61%, a year-on-year decrease of 11.49 pcts.

Cash flow: Net cash flow from the company's operating activities in 2021 was $51 million, compared to $396 million in the same period last year. Net cash flow from 2022Q1's operating activities was $27 million, compared to $48 million for the same period last year.

Profit prediction and valuation: Due to the impact of the pandemic on the birth population and the rise in raw material costs, the previous net profit for 2022/2023 was 26/292 million. After adjustment, we comprehensively estimate the company's net profit for 2022/2023 to be 78 million/153 million yuan, corresponding to 43x/22xPE, maintaining “purchases”

ratings.

Risk warning: risk of international relations, risk of birth rate falling short of expectations, increased competition

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment